本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anaptysbio Inc

26.17
+0.25000.96%
盘后26.170.00000.00%16:04 EDT
成交量:49.55万
成交额:1,316.43万
市值:7.69亿
市盈率:-5.46
高:27.34
开:26.26
低:25.74
收:25.92
数据加载中...
2021/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

重要事件披露

8-K - Current report
2021/01/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report